Clinical Trials Browser

Phase NA × Not yet recruiting × pembrolizumab × Clear all

NCT06549855 2024-08-12

PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer

Phase NA Not yet recruiting

Turcot syndrome, Endometrial Neoplasms, Carcinoma, Endometrioid